Akebia Therapeutics, Inc.
AKBA
Revenue
57.62M
▼-1.14M▼-1.95%
3 Months ChangeAssets
376.57M
▲12.41M▲3.41%
3 Months ChangeLiabilities
343.96M
▲21.40M▲6.63%
3 Months ChangeFree Cash Flow
-13.61M
▲5.83M▲29.99%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001517022-26-000019
2026-01-30
Form 8-K
ID: 0001517022-26-000008
2026-01-12
Form 8-K
ID: 0001517022-26-000003
2025-12-01
Form 8-K
ID: 0001517022-25-000051
2025-11-17
Form 8-K
ID: 0001517022-25-000048
2025-11-10
Form 10-Q
ID: 0001517022-25-000046
2025-11-10
Form 8-K
ID: 0001517022-25-000045
2025-10-28
Form 8-K
ID: 0001517022-25-000040
2025-08-07
Form 10-Q
ID: 0001628280-25-038600
2025-08-07
Form 8-K
ID: 0001517022-25-000034